MedTrace Logo

Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix

NCT01279135 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-02-06

No results posted yet for this study

Summary

The study tests Tomtherapy based Image Guided Radiation against conventional radiation techniques for it's ability to reduce long term small bowel toxicity.

Conditions

  • Cancer Cervix

Interventions

RADIATION

Conventional Radiation

Standard Pelvic Radiation 50 Gy/ 25 fractions over 5 weeks

RADIATION

Tomotherapy based IGRT

Patients in this arm will received Tomotherapy based Image Guided Intensity Modulated Radiotherapy to a dose of 50 Gy/25 fractions/5 weeks

Sponsors & Collaborators

  • Tata Memorial Hospital

    lead OTHER_GOV

Principal Investigators

  • Supriya Chopra, MD,DNB · ACTREC, Tata Memorial Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2019-12-30
Completion
2020-05-05

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279135 on ClinicalTrials.gov